Multispecialty Perspectives on Long COVID-19
Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.
Features
Monoclonal Antibodies for COVID-19: Expert Insights
The IDSA recommends that antibody therapy should be administered to patients with mild to moderate COVID-19 at high risk for progression to severe disease.
ACP Releases Practice Advice for Short-Course Antibiotics in Common Infections
The American College of Physicians convened a panel to identify best practices for the use of short-course antibiotics in the management of common infections.
Risks, Diagnosis, and Management of Sepsis in Patients Undergoing Radiotherapy
Sepsis and septic shock are common oncologic emergencies that require vigilant, timely diagnosis and intervention. Timely and effective detection and treatment of these conditions are key to patient survival.
Dysrhythmias in Patients With COVID-19
Sinus tachycardia is the most commonly reported dysrhythmia in patients with COVID-19 disease.
COVID-19 and IBD: Impact of Disease State and Biologics
In patients with IBD, management of immunosuppressive regimens, as well as safety and efficacy of vaccines, has raised many questions during the COVID-19 pandemic.
COVID-19 and Urticaria: A Case Study
Cutaneous manifestations of COVID-19 are increasingly reported, with urticaria being one of the most common skin symptoms.
Evaluating Accuracy of Antigen, Molecular-Based Point-of-Care COVID-19 Tests
In this expert interview, the performance of the numerous rapid point-of-care testing modalities available for COVID-19 infection is discussed.
The Threat of Gram-Negative Antimicrobial Resistance
Carbapenem-resistant Enterobacterales, extended-spectrum β-lactamase-producing Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance have been designated as urgent or serious threats by the Centers for Disease Control and Prevention.
More Diversity in Medicine, More Equity in Health Care Urgently Needed
The field of medicine has been plagued by the underrepresentation of African Americans, people of Hispanic heritage, and Native Americans, as well as institutional racism and sexism that have persisted for decades.
COVID-19 Vaccination in Pregnant and Nursing Women: Expert Perspectives From Obstetrics and Epidemiology
Experts in the field of obstetrics and epidemiology share how they are helping their patients make informed clinical decisions about vaccination for SARS-CoV-2.
New Guidance: American College of Physicians Discusses Antibody Response in COVID-19 Immunity
To help clinicians and patients determine if antibodies protect against reinfection, the ACP discussed tests for diagnosing and estimating the prevalence of COVID-19.
COVID-19 Vaccine Mandates: Public and Expert Viewpoints
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.
Telemedicine for Hematology During COVID-19 and Beyond
The benefits of telemedicine became more evident in the context of the elevated risk of COVID-19 infection and severe symptoms among the patients served by hematology and oncology practices.
Women Living With HIV Require Better Mental Health Diagnostics and Interventions
In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH.
A Conversation About Racial Disparities in Health Care With Dr Scharles Konadu
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
WHO End Tuberculosis Strategy Progress Stalled in Light of COVID-19
The gains in the global fight against tuberculosis have been threatened as a result of the COVID-19 pandemic, including a diversion of resources that have led to disruptions in ongoing research and control programs.
Moral Judgments and COVID-19 Vaccine Hesitancy
Whatever strategy you employ to encourage vaccinations, it is important to be respectful and empathize with your patient’s concerns and perspectives.
Plant-Based Vaccine Manufacturing for Influenza, Implications for Future Vaccines
An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.
COVID-19 Vaccines and Allergic Reactions: Data Analysis, What You Need to Know
Polyethylene glycol (PEG) found in mRNA-based COVID vaccines, Pfizer and Moderna, have excluded patients due to risk of allergic reactions, including anaphylaxis; the recent approval of Janssen’s COVID-19 vaccine, which contains polysorbate, provides an alternative for this population.
Long-Term Repercussions of Postponing Care Due to COVID-19
Fear of the COVID-19 pandemic has caused patients to cancel or delay necessary cancer screenings, diagnostic tests, wellness exams, elective surgeries, and immunizations; the repercussions of this may be immediate, or not seen for months to years.
COVID-19 Vaccine Efficacy After First Dose: Pfizer, Moderna, AstraZeneca
New data about Pfizer COVID-19 efficacy after the first dose suggests high efficacy, raising questions about potential alternative dosing schedules.
Oxford-AstraZeneca COVID-19 Vaccine: New Study Results, Variant Coverage Update, Where Do We Stand?
The Oxford-AstraZeneca COVID-19 vaccine, ChAdOx1, released 4 studies to analyze its efficacy in the prevention of mild, moderate, and severe COVID-19 infection; new studies also address rising concerns in the vaccine’s ability to protect against variants B.1.1.7 and B.1.351.
But Is it Fair? Bioethics, COVID-19 Vaccine Distribution, and Advocacy
We speak with Mildred Solomon, EdD, President of the Hastings Center and Professor of Global Health and Social Medicine at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, about the COVID-19 pandemic, health equity, and vaccine distribution.
COVID-19 Variants: Pfizer, Moderna Updates, and IDSA Media Briefing
Moderna and Pfizer provide updates on mRNA vaccines against variant B.1.1.7; Infectious Diseases Society of America holds media briefing on COVID-19 variants.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Features
Loading... 
Loading...